Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine
Status:
Terminated
Trial end date:
1997-12-14
Target enrollment:
Participant gender:
Summary
Current therapies for Cancer of the Small Intestine provide very limited benefit to the
patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove
beneficial in the treatment of Cancer of the Small Intestine.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on patients with Cancer of the Small Intestine.